LATEST UPDATES » Vol 23, No 06, June 2019 – Clinical trials — What's in a name?       » Study reveals mechanism behind ginger's warming effect on body       » China proposes major changes to pharmaceutical regulations       » Six plants native to Southeast Asia are promising cancer warriors       » Cancer cells are addicted to methionine       » World's first molecular swing      
Study finds biopharma companies seek digital transformation, but most are lagging
Fourth annual digital business global executive survey reveals cultural, leadership and funding challenges that must be addressed

While many biotech and pharmaceutical companies seek the many competitive advantages that come with digitally transforming their businesses, few biopharma leaders say they have made the changes necessary to achieve their transformational goals, according to new research from Deloitte and MIT.

The 2018 Digital Business Global Executive Study from Deloitte and MIT Sloan Management Review surveyed managers, executives, and analysts across industries and countries. The fourth annual study found that while many biopharma companies are exploring a variety of digital opportunities – from engaging consumers with apps to improving operations with artificial intelligence – just 20 percent of leaders said their companies are digitally maturing.

Where biopharma stands in its digital journey

Most biopharma leaders say their companies are either early in their journey (25 percent) or developing their capabilities (55 percent). Even though most companies are still in their development phase, 58 percent said that digital is a top management priority, with 75 percent expecting to achieve the value of their digital initiatives within the next five years.

So what is holding some biopharma companies back? The survey revealed a number of factors including lack of a clear vision, inadequate leadership, and limited funding for digital transformation.

Even though digital is a priority for more than half of biopharma companies surveyed, some say their organisations can be distracted by “shiny object” syndrome – shifting focus based on what they hear competitors are doing.

Many seek a clearer vision from leadership on their organisation’s digital efforts.

The survey found that many biopharma employees also seek a clearer vision from leadership on their organisation’s digital efforts.

Compared to other industries pursuing digital transformation, biopharma ranks in the middle in terms of its digital maturity and exhibiting the flexible leadership required, the study found. Biopharma is outpacing manufacturing, financial insurance and government organisations in its digital journey, but lagging behind IT, entertainment and telecom companies.

Leadership and funding challenges

When asked about leadership, more than three-quarters of biopharma respondents (78 percent) said their organisation needs to find new leaders to succeed in the digital age. Only 20 percent said their companies are developing the types of leaders who have the capabilities necessary to facilitate the transformation. This means that companies may need to look externally for digital leaders. Some companies are hiring Chief Digital Officers, often from other industries, to lead transformation efforts.

The study also found that many biopharma companies are not willing to fund digital projects or staff them with the necessary resources. Fifty-four percent of respondents agreed that adequate funding is a major drag on digital initiatives.

Click here for the complete issue.

news Discover key nutraceutical trends in Asia Pacific
news Which country has the worst sleepers
news Asia is the fastest growing region for nutraceuticals
news 2018 Nobel Prize in Physiology or Medicine winners
Asia Pacific Biotech News

APBN Editorial Calendar 2019
Taiwan Medical tourism
Marijuana as medicine — Legal marijuana will open up scientific research
Driven by curiosity
Career developments for researchers
What's cracking — Antibodies in ostrich eggs
Clinical trials — What's in a name?
Editorial calendar is subjected to changes.
About Us
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
Copyright© 2019 World Scientific Publishing Co Pte Ltd  •  Privacy Policy